Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01005706 · ClinicalTrials.gov registry record · NA
Sirolimus Conversions in African-American Renal Transplant Recipients
A NA study of Absence; Kidney, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT01005706 is a NA study of Absence; Kidney that has completed, run by Medical University of South Carolina. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01005706, a NA study of Absence; Kidney, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's focus is to compare the level effectiveness and safety of regimens involving Sirolimus, Cellcept and steroid to Prograf, Sirolimus and steroid in African-American recipients of kidney transplants.
Conditions Studied
Interventions
- DRUG rapamune, mycophenolate mofetil and steroid
- DRUG tacrolimus, sirolimus and steroid
Study Locations (1)
South Carolina
- The Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2009-08 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01005706
The ClinicalTrials.gov registry entry for NCT01005706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Absence; Kidney appearing as the primary indexed condition, and to 2 interventions - of which rapamune, mycophenolate mofetil and steroid is the first listed.
NCT01005706 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01005706 about?
NCT01005706 is a clinical study titled "Sirolimus Conversions in African-American Renal Transplant Recipients". This study's focus is to compare the level effectiveness and safety of regimens involving Sirolimus, Cellcept and steroid to Prograf, Sirolimus and steroid in African-American recipients of kidney transplants.
What is the current status of trial NCT01005706?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2009-08. Estimated completion is 2014-07.
What conditions does trial NCT01005706 study?
This clinical trial studies the following conditions: Absence; Kidney.
What interventions are being tested in trial NCT01005706?
The interventions under investigation include: rapamune, mycophenolate mofetil and steroid (DRUG), tacrolimus, sirolimus and steroid (DRUG).
Who is sponsoring clinical trial NCT01005706?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01005706 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.